Meniere's Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Sound Pharmaceuticals

(Las Vegas, Nevada, United States) "DelveInsight's "Meniere's Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Meniere's Disease, historical and forecasted epidemiology as well as the Meniere's Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Download Sample Report to know more
https://www.delveinsight.com/sample-request/menieres-disease-md-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Meniere's Disease Overview
Meniere's disease is a disorder of the inner ear characterized by hearing loss, tinnitus, and vertigo. In Meniere's disease, fluid collects in the inner ear leading to pressure from the buildup of fluid that damages some of the delicate structures in the inner ear causing a variety of symptoms to appear suddenly, without warning, and can last minutes to hours; in most cases, it is slowly progressive.
Meniere's disease is classified into two: Definite Meniere's disease and Probable Meniere's disease. Other subtypes of Meniere's disease include classic Meniere's disease, vestibular Meniere's disease, and bilateral Meniere's disease. Audiometric evaluation and electronystagmogram to check balance are mandatory in all patients with Meniere's disease. Fluctuating low-frequency unilateral sensorineural hearing loss is characteristic of the disease.
The hearing loss can progress to all frequencies. Tinnitus is common and ipsilateral. All patients with one-sided hearing loss should undergo magnetic resonance imaging (MRI) to rule out retro cochlear pathology. High-resolution MRI imaging may directly show endolymphatic hydrops in the affected organs.

Click here to learn more about the Meniere's Disease Market Landscape @https://www.delveinsight.com/report-store/menieres-disease-md-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlight from Meniere's Disease Market Report
The prevalence of Meniere's disease varies between 3.5 per 100.000 and 513 per 100.000 and occurs more often in older, white, female patients.
According to the American Hearing Research Foundation (2021), Meniere's affects roughly 615,000 people in the US, making it a relatively rare disorder, according to current statistics. About 0.2 percent of the US population has it. And each year about 45,500 new cases are diagnosed.
According to the American Hearing Research Foundation (2021), Meniere's disease occurs between 40 and 60 years. And the probability of developing the disorder is fairly equal between both women and men, although some studies show that women may be more likely to be diagnosed with it.

Meniere's Disease Treatment Market
There is no cure for Meniere's disease, so treatment focuses on managing symptoms, hence ideal treatment aims to stop vertigo attacks, restore hearing, and get rid of tinnitus and ear fullness. Furthermore, all current treatment options are symptomatic with common treatments including salt restriction, diuretics and betahistine, intratympanic gentamicin and steroids, ablative surgical therapies endolymphatic sac surgery, and Meniett device. Moreover, specific types of cognitive and behavioral therapies may be helpful in managing the anxiety and/or depression that sometimes accompanies Meniere's. The most disabling symptom of an attack of Meniere's disease is dizziness. Prescription drugs such as meclizine, diazepam, glycopyrrolate, and lorazepam can help relieve dizziness and shorten the attack.

Learn more about the treatment market for Meniere's Disease @ https://www.delveinsight.com/report-store/menieres-disease-md-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

The Report Covers the Meniere's Disease Epidemiology Segmented by:
Meniere's Disease prevalent cases
Meniere's Disease diagnosed prevalent cases
Meniere's Disease diagnosed treatable cases
Meniere's Disease age-specific cases
Meniere's Disease Drug Profile and Companies Covered
Sound Pharmaceuticals: SPI-1005
And many others

Learn more about the Key Companies and Emerging Therapies in the Meniere's Disease Market @ https://www.delveinsight.com/report-store/menieres-disease-md-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Meniere's DiseaseIntroduction
Executive Summary of Meniere's Disease
Disease Background and Overview
Meniere's Disease Epidemiology and patient population
Meniere's Disease Emerging Therapies
Meniere's Disease Market Outlook
Meniere's Disease Market Access and Reimbursement of Therapies
Meniere's Disease Market Drivers
Meniere's Disease Market Barriers
Appendix
Meniere's Disease Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Meniere's Disease Market Outlook report @
https://www.delveinsight.com/report-store/menieres-disease-md-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Related Reports
Meniere's Disease Epidemiology Forecast
https://www.delveinsight.com/report-store/Meniere's Disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Meniere's Disease Pipeline Forecast
https://www.delveinsight.com/report-store/menieres-disease-md-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Media Contact
DelveInsight Business Research LLP
Aditya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.